Dr. Oki O'Connor: New Drugs Targeting Dangerous Cholesterol
Talking Biotech with Dr. Kevin Folta - Un pódcast de Colabra
Specific modifications of cholesterol appear to be central in heart disease, stroke and other disorders. Dr. Matthew "Oki" O'Connor from Underdog Pharmaceuticals speaks about how a cyclical carbohydrate has been modified to potentially reverse these problems that significantly limit lifespan and quality of life.
